Kromek listed on the AIM market in October, 2013 and is a UK company pioneering digital colour imaging for x-rays using cadmium zinc telluride crystals.
$6m contract win for breakthrough biothreat detector
Once the world is fully vaccinated, many investors incorrectly assume there will be no need for...
Read moreEst H2’21 sales (£5.4m) jump 17% vs H1’21 (£4.6m)
After a quiet H1 due to the pandemic, Kromek is now enjoying a powerful rebound for its next...
Read moreOversubscribed £13m fund raise to drive growth
Kromek yesterday confirmed that it had raised £13m gross at 15p/share from existing and new...
Read more
Substantial airborne Covid detector opportunity
Great to see vaccines being rolled out, but countries will also require an early warning system to...
Read moreNew contracts being won right across the board
The US was the first to recognise the danger, but since then other Western nations have woken up to...
Read more
Through the eye of the Covid storm
‘What doesn’t kill you makes you stronger’. Ditto for radiation detection expert Kromek, which was...
Read moreRevolutionary new pathogen detector
Many of the world’s best and most important products (eg Space exploration, nuclear medicine/power...
Read moreCOVID-19 impacts short-term outlook
Operating theatres have been converted into ICUs and non-critical procedures understandably...
Read moreOn the road towards mainstream adoption
Occasionally on the FTSE, there can be such a wide disconnect between price & value that it is...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
